Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples